Abstracts tagged "Work Disability and psoriatic arthritis"

Abstract Number: 1640 • 2018 ACR/ARHP Annual Meeting
Work Disability in Psoriatic Arthritis Patients
Raul Sueldo¹, Luciana Sofia Garay¹, Luciana Gonzalez Lucero², Maria Constanza Bertolaccini², Ramiro Maldonado², Ana Lucia Barbaglia², Veronica Bellomio², Maria de la Paz Leon², Francisco Javier Hüttmann², Yessika Soria Curi², Susana Mazza², Maria Lilia Leguizamon², Mirta Santana¹, Liliana Galindo², Julia Demarchi³, Silvia Beatriz Papasidero⁴, Maria M Zalazar⁵, Oscar Rillo⁴ and Eleonora Lucero¹, ¹Hospital Angel C. Padilla, Tucumán, Argentina, ²Hospital Angel C. Padilla, Tucuman, Argentina, ³Hospital E. Tornu, Buenos Aires, Argentina, ⁴Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, CABA, Argentina, ⁵Hospital Dr. Ignacio Pirovano, Buenos Aires, Argentina
Background/Purpose: Psoriatic Arthritis (PsA) is an inflammatory disease with an important impact on the quality of life and work productivity. Although the activity of the…
Abstract Number: 315 • 2013 ACR/ARHP Annual Meeting
Long Term Outcomes In Psoriatic Arthritis 2; A Prospective Multicentre Observational Study Of Work Disability In Psoriatic Arthritis: First Report Of The Clinical and Socioeconomic Associations Of Work Disability In Psoriatic Arthritis
William Tillett¹, Gavin Shaddick², Ayman Askari³, Annie Cooper⁴, Paul Creamer⁵, Gavin Clunie⁶, Philip S. Helliwell⁷, Lesley Kay⁸, Eleanor Korendowych¹, Suzanne Lane⁹, Jonathon Packham¹⁰, Ragai Shaban¹¹, Lyn Williamson¹², Corinne deVries¹³ and Neil McHugh¹⁴, ¹Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ²Department of Mathematics, University of Bath, Bath, United Kingdom, ³Robert Jones and Agnes Hunt Hospital, Shrophire, United Kingdom, ⁴Rheumatology, Royal Hampshire County Hospital, Winchester, United Kingdom, ⁵Rheumatology, North Bristol NHS foundation trust, Bristol, United Kingdom, ⁶Rheumatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, ⁷PsAID taskforce, EULAR, Zurich, Switzerland, ⁸Department of Rheumatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, ⁹Rheumatology, Ipswich Hospital NHS Trust, Ipswich, United Kingdom, ¹⁰Rheumatology, Haywood Rheumatology Centre, Stoke-on-Trent, United Kingdom, ¹¹Rheumatology, Queen Alexandra Hospital, Portsmouth, United Kingdom, ¹²Rheumatology, Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom, ¹³Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, ¹⁴Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom
Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that is associated with joint damage, impaired quality of life and high levels of work disability…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].